Search - tctmd.com

Displaying 61 - 80 of 203

Sort: Relevancy | Date

Presentation TCT 2024

TCT 759: Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis

Presenter: Juan del Portillo

October 27, 2024

Presentation TCT 2024

TCT 124: Timing of Intraprocedural Conduction Disturbances in TAVR: Predicting Subsequent Pacemaker Implantation and RV Pacing

Presenter: Jason Galo

October 27, 2024

Presentation NY Valves 2024

SAVR Transaxillary Approach: Pushing the Boundaries

Presenter: Joerg Kempfert

June 07, 2024

Presentation NY Valves 2024

Transaxillary Non-Robotic SAVR – Yet Another Option

Presenter: Joerg Kempfert

June 06, 2024

Presentation NY Valves 2024

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

SAVR After TAVR: A Dangerous Epidemic?

Presenter: Shinichi Fukuhara

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

SAVR for the Small Annulus Patient – Surgical Trends and Perspectives

Presenter: Hendrik Treede

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Presentation NY Valves 2024

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Presenter: Mark Lebehn

June 06, 2024

Presentation NY Valves 2024

Defining the Small Annulus Patient: TAVR and SAVR Perspectives

Presenter: Dee Dee Wang

June 06, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation Miami Valves 2024

Valve in Valve for SAVR Degeneration with Aortic Insufficiency & Shock

Presenter: Som Bailey

February 03, 2024

Presentation Miami Valves 2024

Advanced Planning and Simulation for Valve in Valve TAVR and SAVR

Presenter: Nicolas M. Van Mieghem

February 01, 2024

Presentation STS 2024

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Presenter: Jad Malas

January 27, 2024

Presentation TCT 2023

TCT 59: Surgical Aortic Valve Deterioration: Time to redo-SAVR in Trifecta versus non-Trifecta Valves

Presenter: Mazhed Kheyrbek

October 26, 2023

Advertisement

TCT 759: Transcarotid Versus Surgical Aortic Valve Replacement for the Treatment of Severe Aortic Stenosis

TCT 124: Timing of Intraprocedural Conduction Disturbances in TAVR: Predicting Subsequent Pacemaker Implantation and RV Pacing

SAVR Transaxillary Approach: Pushing the Boundaries

Transaxillary Non-Robotic SAVR – Yet Another Option

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

SAVR After TAVR: A Dangerous Epidemic?

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

SAVR for the Small Annulus Patient – Surgical Trends and Perspectives

SAVR Will Have a Longer Lasting Durability Than TAVR

Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands

TAVR Will Have a Longer Lasting Durability Than SAVR

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Defining the Small Annulus Patient: TAVR and SAVR Perspectives

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Valve in Valve for SAVR Degeneration with Aortic Insufficiency & Shock

Advanced Planning and Simulation for Valve in Valve TAVR and SAVR

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

TCT 59: Surgical Aortic Valve Deterioration: Time to redo-SAVR in Trifecta versus non-Trifecta Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content